Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03502577
Title BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
Recruitment Suspended
Phase Phase I
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center

multiple myeloma


Anti-BCMA CAR T Cells + Cyclophosphamide + Fludarabine + LY3039478

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.